| Literature DB >> 15345058 |
Karin Nygård1, Birgitta de Jong, Philippe J Guerin, Yvonne Andersson, Agneta Olsson, Johan Giesecke.
Abstract
BACKGROUND: Among human Salmonella Enteritidis infections, phage type 4 has been the dominant phage type in most countries in Western Europe during the last years. This is reflected in Salmonella infections among Swedish travellers returning from abroad. However, there are differences in phage type distribution between the countries, and this has also changed over time.Entities:
Mesh:
Year: 2004 PMID: 15345058 PMCID: PMC518973 DOI: 10.1186/1741-7015-2-32
Source DB: PubMed Journal: BMC Med ISSN: 1741-7015 Impact factor: 8.775
Figure 1Incidence rates (IR) of Salmonella Enteritidis infections among Swedish travellers to Spain, Greece and Turkey. Country specific annual incidence rate of Salmonella Enteritidis per 100,000 air travellers from Sweden. Incidence rates are calculated based on the number of cases notified to the Swedish infectious Disease register using the number of flight passengers from Sweden to the first foreign destination as the denominator.
Figure 2Distribution of phage types of Salmonella Enteritidis cases notified in Sweden, 1997 to 2002.
Figure 3Dominant phage types of Salmonella Enteritidis infections among Swedish travellers according to country visited. Only countries with more than 10 reported cases and phage types accounting for > 25 % of all cases are shown. a) 1997 – 2000 b) 2001
Figure 4Notified cases of Salmonella Enteritidis PT 14b among Swedish travellers by country of infection, 1997 – 2002.
Dominant Salmonella Enteritidis phage types by country*. Comparison between findings among Swedish travellers and studies conducted in the countries visited.
| Country | Number of | Most common | Predominant phage type described in studies from the country visited | Year of study | Reference |
| Spain | 4125 | 1 (33%), 4 (36%) | 1, 4, 6 | 1990s | [29] |
| Greece 1997–2000 | 916 | 4 (44%) | |||
| Turkey | 496 | 4 (65 %) | 4 | Not mentioned | [30] |
| Poland | 354 | 4 (40 %) | 4, 8 | 1986–95 | [31] |
| Portugal | 344 | 1 (43 %) | |||
| Morocco | 310 | 4 (50 %) | |||
| Germany | 235 | 4 (59%) | 4 | 1998 | [32] |
| Denmark 1997–1998 | 223 | 6 (42%), 8 (43%) | 6, 8 | 1997–98 | [33] |
| Czech Republic | 194 | 8 (68%) | 8 | 1989–98 | [34] |
| Bulgaria | 180 | 4 (55% | |||
| Cyprus | 166 | 1 (36%), 4 (45%) | |||
| Tunisia | 152 | 4 (75%) | |||
| Italy | 152 | 4 (47%) | 4 | 1990–93 | [29,35] |
| United Kingdom | 133 | 4 (76%) | 4 | 1997–2000 | [36] |
| Hungary | 120 | 4 (50%) | 4 | 1992–94 | [37] |
| France | 110 | 4 (56%) | |||
| Austria 1997–2000 | 81 | 4 (52%), 8 (38%) | 4 | 1995–2001 | [6] |
| Latvia 1997–2000 | 76 | 1 (63%) | |||
| Egypt | 63 | 4 (55%) | |||
| Croatia | 53 | 4 (63%) | |||
| Belgium | 45 | 4 (72%) | |||
| Russia | 42 | 1 (62%) | 1 | 1980–93 | [38] |
| Estonia 1997–2000 | 37 | 1 (58%) | |||
| Bosnia and Herzegovina | 26 | 4 (64%) | |||
| The Netherlands | 20 | 4 (75%) | 4 | 1997–2001 | [6] |
| Slovakia | 14 | 8 (62%) | 8 | 1995 | [39] |
| Lithuania | 12 | 1 (50%) |
* Calculated as a percentage of all isolates that were phage-typed during 1997–2001.
** Based on less than 10 cases.